Antileukemic effect of venetoclax and hypomethylating agents via caspase-3/GSDME-mediated pyroptosis

BACKGROUND: The identifying of B-cell lymphoma 2 (Bcl-2) as a therapeutic target has led to a paradigm shift in acute myeloid leukemia (AML) treatment. Pyroptosis is a novel antitumor therapeutic mechanism due to its cytotoxic and immunogenic effects. The combination of venetoclax and hypomethylatin...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Fanghua, Zhang, Wen, Fan, Chenying, Dong, Jiajia, Peng, Min, Deng, Wenjun, Zhang, Hui, Yang, Liangchun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10486003/
https://www.ncbi.nlm.nih.gov/pubmed/37679782
http://dx.doi.org/10.1186/s12967-023-04481-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10486003/
https://www.ncbi.nlm.nih.gov/pubmed/37679782
http://dx.doi.org/10.1186/s12967-023-04481-0

Ejemplares similares